The Molecular Biology of Midgut Neuroendocrine Neoplasms

Amy P Webster1, Chrissie Thirlwell1,2

  • 1Department of Clinical and Biomedical Science, University of Exeter College of Medicine and Health, Exeter, EX2 5DW, UK.

Endocrine Reviews
|December 20, 2023
PubMed

Insights

Midgut neuroendocrine neoplasms (NENs), a common small intestine cancer, have rising incidence and poorly understood molecular biology. Research into their genetic, epigenetic, and transcriptomic factors is crucial for better patient outcomes.

Area of Science:

  • Oncology
  • Gastroenterology
  • Molecular Biology

Background:

  • Midgut neuroendocrine neoplasms (NENs) are a frequent small intestine malignancy with increasing global incidence.
  • Despite their prevalence, the molecular underpinnings of midgut NENs remain largely unknown.
  • Unique characteristics include a low mutational burden and multifocal tumor occurrence, prompting research into their biology.

Purpose of the Study:

  • To review recent advancements in understanding the molecular biology of midgut NENs.
  • To explore the interplay of genetic, epigenetic, and transcriptomic factors in midgut NEN development.
  • To highlight the importance of this research for improving patient treatment and outcomes.

Main Methods:

  • Literature review of recent studies on midgut NEN molecular biology.
  • Analysis of genetic, epigenetic, and transcriptomic data.
  • Synthesis of current understanding of NEN development.

Main Results:

  • Recent research has shed light on the complex molecular landscape of midgut NENs.
  • The interplay between genetic, epigenetic, and transcriptomic alterations is critical in NEN pathogenesis.
  • Understanding these molecular details is key to identifying novel therapeutic targets.

Conclusions:

  • Further research into the molecular biology of midgut NENs is essential.
  • Advances in understanding the genetic, epigenetic, and transcriptomic landscape will drive improved diagnostics and therapeutics.
  • This knowledge is critical for enhancing treatment strategies and patient survival rates for midgut NENs.